GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/GI Surgery/TIVA vs Inhalational Anaesthesia in Major Noncardiac Surgery: JAMA | August 2026
5

TIVA vs Inhalational Anaesthesia in Major Noncardiac Surgery: JAMA | August 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated August 1, 2026

Introduction:

Total intravenous anaesthesia (TIVA) with propofol is increasingly used as an alternative to volatile inhalational anaesthesia, with proposed advantages in postoperative recovery and safety. However, robust evidence demonstrating better patient-centred outcomes has been lacking. The VITAL trial compared these two widely used anesthetic strategies in older adults undergoing major elective noncardiac surgery.

Why was this study needed?

TIVA use has expanded considerably despite limited large randomized evidence.

Anesthetic technique may influence postoperative recovery, complications, and delirium.

Previous studies suggested less nausea and faster early recovery with TIVA.

A pragmatic comparison was needed to determine whether these differences translate into meaningful clinical benefit.

Results:

Among 2,508 patients across 49 UK hospitals, days alive and at home at 30 days were virtually identical with TIVA and inhalational anesthesia.

There were no meaningful differences in mortality, major postoperative complications, delirium, or overall quality of recovery.

TIVA produced fewer minor symptoms, including postoperative nausea and vomiting, thirst, and hoarseness.

Two cases of probable or definite intraoperative awareness occurred, both with TIVA, although events were too few for firm conclusions.

Clinical Impact:

For major noncardiac surgery, TIVA does not appear to improve major postoperative outcomes compared with volatile anesthesia. Choice of anesthetic technique can therefore be individualized according to patient characteristics, postoperative nausea risk, procedural requirements, clinician expertise, and environmental considerations rather than an expectation of superior overall recovery.

Bottom Line:

TIVA and volatile inhalational anesthesia provide comparable major clinical outcomes after elective noncardiac surgery. TIVA reduces some minor postoperative symptoms but does not improve overall recovery, mortality, delirium, or major complications.

Related Q&A

06

Robot-Assisted Pancreatoduodenectomy: Annals of Surgery | August 2026

Introduction: Robot-assisted pancreatoduodenectomy (RPD) is increasingly adopted in high-volume pancreatic centers, but concerns remain regarding its higher operative and equipment costs compared with open pancreatoduodenectomy (OPD). This study...

07

Should Age Limit Curative Surgery for Gallbladder Cancer?: BJS Open | August 2026

Introduction: Gallbladder cancer (GBC) is an aggressive malignancy in which surgical resection remains the only potentially curative treatment. Older adults are often considered poor candidates for major hepatobiliary...

08

Emergency Colorectal Cancer Surgery Carries a Higher Risk of Incomplete Tumour Resection: BJS Open | August 2026

Introduction: Approximately 30% of patients with colorectal cancer present as a surgical emergency, most commonly because of bowel obstruction or perforation. While poorer outcomes after emergency surgery are...

09

Indocyanine Green Fluorescent Cholangiography During Laparoscopic Cholecystectomy: JAMA Surgery | July 2026

Introduction: Common bile duct (CBD) injury is one of the most serious complications of laparoscopic cholecystectomy. This large national cohort study evaluated whether indocyanine green (ICG) fluorescent cholangiography...

10

Preoperative HbA1c Optimisation: Annals of Surgery | July 2026

Introduction: Diabetes is a well-recognised risk factor for postoperative complications, but the optimal level of preoperative glycemic control remains uncertain. This large multi-institutional study evaluated how HbA1c levels...

11

Thromboprophylaxis After Bariatric Surgery: BJS Open | August 2026

Introduction: Patients undergoing metabolic bariatric surgery are at risk for both venous thromboembolism (VTE) and postoperative bleeding. However, the optimal timing and duration of thromboprophylaxis remain uncertain. This...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer